Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 14, 2020 05:46PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Since it's the same CUSPID for those of us in the States (or anyone that can trade on US OTC), one can purchase ZHCLF for below $0.50 on the grey market then hope for the $15-$20 buyout price? Almost seems it's worth the bet. Said differently, I'm skeptical it will work itself out ;)